OncoMethylome Sciences Closes License Agreement With Veridex For Detection Of Prostate Cancer
OncoMethylome Sciences licenses molecular test based on DNA methylation
26-Jan-2005 -
OncoMethylome Sciences, a company developing advanced molecular diagnostic solutions for individualized cancer treatment and early detection of cancer, announced a license agreement with Veridex LLC, a Johnson & Johnson company.
Under the agreement, Veridex receives an exclusive global license ...
DNA methylation
license agreements
milestone payments
+1